Install
Anxiety & Mood Disorders
Recognition, treatment, relapse prevention, and lived‑experience stories.
- 4 Tracked terms
- Last 30 days Feed window
What this topic collects on
An article joins this feed when it matches these terms. Each one is also a search of its own.
Related topics
Latest in Anxiety & Mood Disorders
MedFest Egypt Panel Sheds Light on Trauma & Imagination
3+ hour, 6+ min ago (1018+ words) MedFest Egypt’s eighth edition featured a screening of the “After” programme, followed by a discussion exploring the films’ treatment of trauma, isolation, public spaces, imagination and the cinematic process. The session brought together editor Sarah Abdullah, filmmaker Mohamed Hammad and…...
Young social media use linked to anxiety and depression as teen
27+ min ago (852+ words) The younger a child starts using social media the more likely they are to suffer anxiety or depression as teenagers, suggests a new study. Researchers found the age at which adolescents first start using social media may be more important…...
Coffee: Just the Smell May Boost Your Mood
3+ hour, 59+ min ago (668+ words) A holistic guide to care A guide to therapy, medications, and techniques for managing anxiety Nutrition tips and tools for supporting mental well-being Resources for finding and receiving therapy The rich, tempting aroma of coffee may be benefiting your mood…...
Over 1M SC women feel overwhelmed, but that???s good?
4+ hour, 3+ min ago (792+ words) The errands may eventually get done. The work of remembering them rarely does. For many women, pressure does not come from one dramatic source. It accumulates quietly: work deadlines, household bills, grocery lists, medical appointments, childcare, aging relatives and the…...
Lipocine starts second Phase III for postpartum depression drug after first trial misses endpoint
6+ hour, 45+ min ago (589+ words) AllSci Salt Lake City-based Lipocine Inc. (Nasdaq: LPCN) has initiated BLOOM, a second Phase III study of LPCN 1154 (oral brexanolone, proposed brand name Brlizio) for severe postpartum depression (PPD), after its first Phase III trial missed its primary endpoint earlier…...
How art is helping shape the next generation of doctors
2+ hour, 29+ min ago (1373+ words) It was the final class of the school year, and three medical school students stood before their classmates in a Colorado Springs lecture hall with this question: Could art help them become better doctors? Medical school students spend years studying…...
J&J/Contineum depression candidate fails in phase 2
2+ hour, 52+ min ago (18+ words) J&J’s JNJ-5120 (PIPE-307) missed its phase 2 MOONLIGHT-1 primary endpoint in major depressive disorder. Read more here....
Why Mudita Is a Therapist's Superpower
10+ hour, 14+ min ago (212+ words) Posted September 14, 2026 | Reviewed by Devon Frye In addition, many people subconsciously and consciously perceive the world as a zero-sum game, a finite pie that means if someone else takes a slice then there's one less for them. We're all familiar…...
Contineum, J&J’s depression drug fails to meet mid-stage trial goal
3+ hour, 4+ min ago (209+ words) Sept 15 (Reuters) – Contineum Therapeutics said on Monday an experimental depression drug it developed with Johnson & Johnson failed to meet the main goal of a mid-stage study. • The trial was testing the drug, JNJ-5120 or PIPE-307, in patients with major depressive disorder,…...
Recalibrate Your Mindset
15+ hour, 41+ min ago (102+ words) Your brain is wired to notice what’s going wrong. Under stress, that tendency can narrow your attention and make progress harder to see. Recalibrating your mindset means deliberately giving your brain more evidence of what’s working. A few simple habits…...